Cassava Sciences (SAVA) Stock Price
$1.9 32.1%
to add to portfolio
AI Score

-
Alternative
0 -
Fundamental
1 -
Technical
2
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Cassava Sciences, AI stock picks, stock alerts and much more.
SAVA AI Stock Analysis
AI stock analysis for SAVA is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Cassava Sciences (SAVA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Cassava Sciences (SAVA) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Cassava Sciences (SAVA), currently trading at $1.9, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About SAVA

-
Cassava Sciences, Inc.
-
Symbol
SAVA
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
91.8M
Similar Stocks
![]() |
Catalyst Pharmaceuticals CPRX |
$25.72 0.1% |
5 |
![]() |
Inovio Pharmaceuticals INO |
$1.81 3.7% |
2 |
![]() |
Moderna MRNA |
$33.85 0.9% |
3 |
![]() |
Anavex Life Sciences AVXL |
$9.56 0.5% |
5 |
![]() |
BridgeBio Pharma BBIO |
$36.74 1.3% |
5 |
News
SAVA Alternative Data
Web Traffic
Cassava Sciences receives an estimated 399488 monthly visitors to cassavasciences.com.
-
Web Traffic
399488
-
Change from Previous Month
11%
-
3 Month Change
5.8%
-
YoY Change
5.8%
News Mentions
Cassava Sciences was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
100%
Reddit Mentions
Cassava Sciences has been mentioned an estimated 2 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
2
-
Daily Change
100%
-
1 Month Change
100%
Job Postings
Cassava Sciences currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, Cassava Sciences has 37 employees.
-
LinkedIn Employees
37
-
Daily Change
2.8%
-
1 Month Change
0%
-
3 Month Change
0%
SAVA Financials
SAVA Key Metrics
-
Total Revenue
$0
-
Net Income
-$27.9M
-
Earnings per Share
-$0.58
-
Free cash flow
-$18.3M
-
EBITDA
-$30.4M
-
EBITDA Ratio
0
-
Total Assets
$223.8M
SAVA 2-year Revenue & Income
SAVA 2-year Free Cash Flow
SAVA Technicals
SAVA SMA
SAVA RSI
FAQ
What's the current price of Cassava Sciences (SAVA) Stock?
The price of an Cassava Sciences (SAVA) share is $1.9.
What's the market cap of Cassava Sciences?
The current market cap of Cassava Sciences is 91.8M.
Should I buy or sell SAVA?
Cassava Sciences exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Cassava Sciences a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Cassava Sciences stock. There are several bearish signals and market challenges that could negatively impact Cassava Sciences' future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Cassava Sciences (SAVA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Cassava Sciences stock right now, as the outlook appears bearish.
What are some stocks similar to Cassava Sciences (SAVA) that investors often compare it to?
Cassava Sciences (SAVA) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Cassava Sciences' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Cassava Sciences' stock price to be around $1.59 in 2026. Starting from the current price of $1.9, this represents a 16.3% change in price, indicating a bearish outlook for the stock.
How to buy Cassava Sciences (SAVA) Stock?
Cassava Sciences stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Cassava Sciences shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.